Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy A Norris

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 6, 2003
Blood coagulationLucy A Norris
Journal of Thrombosis and Haemostasis : JTH|May 13, 2023
"Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis": CommentLucy A Norris, Feras Abu Saadeh
Thrombosis and Haemostasis|March 30, 2007
Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?Jeanette F Brosnan, Brian L Sheppard, Lucy A Norris
Journal of Thrombosis and Haemostasis : JTH|November 7, 2025
Mechanisms of anticancer treatment-induced arterial and venous thrombosisPablo Albasanz-García, Mark P Ward, Lucy A Norris
Thrombosis Research|May 5, 2005
The effect of LMWH (tinzaparin) on coagulation and fibrinolytic activation in pregnant women at risk of thrombosisMisaho Yoneda, Jeanette F Brosnan, Lucy A Norris, et al.
Thrombosis Research|May 5, 2005
LPS induced tissue factor expression in the THP-1 monocyte cell line is attenuated by conjugated linoleic acidLucy A Norris, Sinead Weldon, Anne Nugent, et al.
Thrombosis and Haemostasis|October 7, 2004
Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic studyLucy A Norris, John Bonnar, Mark P Smith, et al.
Thrombosis and Haemostasis|August 12, 2008
Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestoneLucy A Norris, Jeanette Brosnan, John Bonnar, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Tinzaparin sodium for thrombosis treatment and prevention during pregnancyMark P Smith, Lucy A Norris, Philip J Steer, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 27, 2013
Estrogen receptor alpha augments changes in hemostatic gene expression in HepG2 cells treated with estradiol and phytoestrogensLynne A Kelly, Dana Seidlova-Wuttke, Wolfgang Wuttke, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 6, 2003
Blood coagulationLucy A Norris
Journal of Thrombosis and Haemostasis : JTH|May 13, 2023
"Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis": CommentLucy A Norris, Feras Abu Saadeh
Thrombosis and Haemostasis|March 30, 2007
Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?Jeanette F Brosnan, Brian L Sheppard, Lucy A Norris
Journal of Thrombosis and Haemostasis : JTH|November 7, 2025
Mechanisms of anticancer treatment-induced arterial and venous thrombosisPablo Albasanz-García, Mark P Ward, Lucy A Norris
Thrombosis Research|May 5, 2005
The effect of LMWH (tinzaparin) on coagulation and fibrinolytic activation in pregnant women at risk of thrombosisMisaho Yoneda, Jeanette F Brosnan, Lucy A Norris, et al.
Thrombosis Research|May 5, 2005
LPS induced tissue factor expression in the THP-1 monocyte cell line is attenuated by conjugated linoleic acidLucy A Norris, Sinead Weldon, Anne Nugent, et al.
Thrombosis and Haemostasis|October 7, 2004
Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic studyLucy A Norris, John Bonnar, Mark P Smith, et al.
Thrombosis and Haemostasis|August 12, 2008
Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestoneLucy A Norris, Jeanette Brosnan, John Bonnar, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Tinzaparin sodium for thrombosis treatment and prevention during pregnancyMark P Smith, Lucy A Norris, Philip J Steer, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 27, 2013
Estrogen receptor alpha augments changes in hemostatic gene expression in HepG2 cells treated with estradiol and phytoestrogensLynne A Kelly, Dana Seidlova-Wuttke, Wolfgang Wuttke, et al.
Pageof 2